103. Vaccines Against Herpes Virus
Friday, October 4, 2013: 10:30 AM-12:00 PM
Room: The Moscone Center: 130-131 (Hall E)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • compare and contrast the likelihood of controlling different herpes viruses
  • recognize the potential for recombination between herpes virus vaccines
  • summarize how successful vaccines might affect their clinical practice

Target Audience: vaccinologists, scientists, researchers, microbiologists, lab personnel, investigators, infectious diseases physicians, infectious diseases pediatricians, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID

Moderator:  Paul Griffiths, MD, University College London

CME Credits: No CME credit offered for this session.

ACPE Credits: No CPE credit offered for this session.

ACPE Number:


P. Griffiths, Genentech: Grant Investigator, Research support
Sanofi Pasteur: Collaborator, Research support
Astellas: Scientific Advisor, Research support

J. Devlin, None

T. Heineman, GSK Vaccines: Employee and Shareholder, Salary

M. R. Schleiss, Hookipa Biotech: Scientific Advisor, Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.